Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 30.40
+0.04 (0.13%)
At close: Apr 21, 2026
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 11.13 billion as of April 20, 2026. Its market cap has increased by 25.98% in one year.
Market Cap
11.13B
Enterprise Value
9.86B
Revenue
230.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.40
Market Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 11.13B, a decrease of -10.76%. That is a compound annual growth rate of -3.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 11.13B | 11.45% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
| Jun 20, 2023 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 12.75B |
| Pacific Shuanglin Bio-pharmacy | 12.24B |
| Chengdu Olymvax Biopharmaceuticals | 11.81B |
| Hualan Biological Vaccine | 11.76B |
| Chengdu Easton Biopharmaceuticals | 11.53B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 11.43B |
| Aurisco Pharmaceutical | 11.19B |
| HitGen | 10.73B |